The new SPAC intends to focus its search on target business addressing a large market opportunity with a company that is driving its growth in the medicinal cannabis or cannabinoid industry, which is compliant with all applicable laws and regulations within the jurisdictions in which it is located or operates. Canna-Global is led by CEO J. Gerald Combs, CFO George Yap, Chairperson of the Board’s Compensation Committee and Member of the Board’s Audit Committee Thavaraj Subramaniam, Chairperson of the Board’s Governance and Nomination Committee Dr. Wian Stander, Chairperson of the Board’s Audit Committee and Member of the Board’s Compensation Committee Peng Kong, and Member of the Board’s Governance and Nomination Committee and Compensation Committee Kah Yong Tham.
Total SPAC deal count for 2021 year-to-date is now 560. This offering is expected to close on Thursday, December 2.
EF Hutton, a division of Benchmark Investments, LLC, is acting as the sole book-running manager for the offering. Rimon P.C. is serving as Issuer’s Counsel with Schiff Hardin LLP serving as Underwriter’s Counsel. MaloneBailey, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.